Antilymphocyte induction: effective immune suppression when the stakes are high?
Gaber
A Osama
AO
Methodist Transplant Center, Department of Surgery, The Methodist Hospital, Houston, Texas 77030, USA. AOGaber@tmhs.org
D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000037:antagonists & inhibitors; D018570:Risk Assessment
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2